Rapid and reversible modulation of T4 (CD4) on monocytoid cells by phorbol myristate acetate: effect on HIV susceptibility.
The effect of phorbol myristate acetate (PMA) on T4 (CD4) expression by monocytoid cells was studied. Greater than 99% of untreated U937 and HL-60 cells expressed surface T4 as measured with a fluorescence-activated cell sorter. The percentage of T4 positive cells decreased to less than 20% after incubation with PMA (10(-8) M). A decrease was observed within 15 min of PMA exposure, was maximal within 1 hr, and persisted for at least 3 days in the continuous presence of PMA. The susceptibility of untreated and PMA-treated U937 cells to human immunodeficiency virus (HIV) was also studied. Pretreatment of cells with PMA for 18 hr decreased the production of viral RNA and p24 antigen 24 hr after infection. The dose of PMA resulted in a parallel reduction of both T4 expression and infection by HIV. When PMA was washed from cultures and replaced with fresh medium for 48 hr, then T4 expression and the production viral RNA and p24 antigen following infection were restored. These data suggest that pharmacologic manipulation of surface T4 expression may have a potential role in the prevention or treatment of HIV infection.
Firestein
G S
GS
Department of Medicine, UCSD School of Medicine, San Diego, California 92161.
Reifler
D
D
Richman
D
D
Gruber
H E
HE
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000943:Antigens, Differentiation / Q000032:analysis* / Q000276:immunology; D000954:Antigens, Surface / Q000032:analysis; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D007700:Kinetics; D009000:Monocytes / Q000187:drug effects / Q000276:immunology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D000943:Antigens, Differentiation; D000954:Antigens, Surface; D013755:Tetradecanoylphorbol Acetate